Summary
This 8-K filing by Gilead Sciences, Inc. (GILD) on May 17, 2011, primarily reports on the outcomes of its Annual Meeting of Stockholders held on May 12, 2011. Key corporate governance and compensation matters were voted upon and approved by the stockholders. The most significant event for investors is the stockholder approval of the Amended and Restated Gilead Sciences, Inc. Code Section 162(m) Bonus Plan. This plan's term has been extended for another five years, and the maximum bonus payout per participant has been increased from $5 million to $7 million annually, effective January 1, 2011. Additionally, the filing details stockholder approval for amendments to the company's Restated Certificate of Incorporation and Amended and Restated Bylaws to adopt majority voting standards and to allow holders of at least 20% of voting power to call a special meeting. The election of 12 directors and the ratification of Ernst & Young LLP as the independent auditor were also confirmed. The advisory vote on executive compensation will now be held annually, following stockholder preference.
Key Highlights
- 1Stockholder approval of the Amended and Restated Code Section 162(m) Bonus Plan, extending its term through the 2016 annual meeting.
- 2Increase in the maximum bonus payout per participant under the 162(m) Plan from $5 million to $7 million annually.
- 3Adoption of majority voting standards for director elections by amendment to the Restated Certificate of Incorporation.
- 4Amendments to Bylaws allowing stockholders holding at least 20% of voting power to call a special meeting.
- 5Election of 12 directors to the Board of Directors.
- 6Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2011.
- 7Annual advisory vote on executive compensation confirmed based on stockholder preference for 'One Year' frequency.